Dr Janet Chamberlain
BSc PhD SFHEA
Clinical Medicine, School of Medicine and Population Health
Senior University Teacher
+44 114 215 9566
Full contact details
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
葫芦影业
S10 2RX
- Profile
-
For enquiries please contact - ClinMed-Operational@sheffield.ac.uk
After completing an MRC-funded PhD studentship at the University of Manchester, I spent a year working as an immunohistochemist at Zeneca Pharmaceuticals, Alderley Park. I joined the University of 葫芦影业 in 1995, and spent 3 years as a Postdoctoral Research Associate in the Department of Cardiovascular Research (with Professor David Crossman as PI).
Following this, I wrote my own funding applications, although remained as a Postdoctoral Research Associate, then an Experimental Officer; holding several Project Grants as Principal Investigator, working closely with Professors Sheila Francis and Julian Gunn. In 2016, I became a University Teacher and now concentrate mainly on teaching, although still have an interest in research.
Current PhD Opportunities
- Research interests
-
My research career has focused on the understanding and prevention of restenosis and atherosclerosis, using several different experimental models, including research to develop a miniature stenting device for use in small calibre vessels.
My current areas of research relate to the mechanisms by which IL-1 is released from endothelial and smooth muscle cells, the role of IL-1 in the development of atherosclerosis, and the use of IL-1 antagonists to inhibit disease progression.
In addition, I am currently involved in investigating the role of carbon monoxide as a possible therapeutic for restenosis and myocardial infarction.
Current Projects
- Release of IL-1 from endothelial and smooth muscle cells (with Professor Francis).
- The use of carbon-monoxide releasing molecules in Restenosis/atherosclerosis (BHF, with Francis/Gunn/Mann).
- The use of carbon-monoxide releasing molecules in MI (BHF with Gunn/Iqbal/Francis/Mann).
- Cholesterol crystal formation in atherosclerosis (with Francis).
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Journal of the American Heart Association, 7(13).
- . Pulmonary Circulation, 8(1), 1-11.
- . Annals of Biomedical Engineering, 44(2), 453-465.
- . Journal of Biological Chemistry, 290, 24067-24078.
- . Ann Neurol, 75(5), 670-683.
- . J Exp Med, 209(11), 1919-1935.
- . JOURNAL OF THE AMERICAN HEART ASSOCIATION, 1(3).
- . Arterioscler Thromb Vasc Biol, 31(9), 1988-1990.
- . Atherosclerosis, 215(2), 348-354.
- . Am J Pathol, 179(4), 1693-1705.
- . Cardiovasc Res, 85(1), 38-44.
- . Circulation, 119(1), 116-122.
- . PLoS One, 4(4), e5073.
- . Am J Pathol, 168(4), 1396-1403.
All publications
Journal articles
- . Frontiers in Cellular and Infection Microbiology, 13.
- . Vascular Biology.
- . Journal of Cardiovascular Pharmacology, Publish Ahead of Print.
- . Journal of the American Heart Association, 7(13).
- . Pulmonary Circulation, 8(1), 1-11.
- . Annals of Biomedical Engineering, 44(2), 453-465.
- . Journal of Biological Chemistry, 290, 24067-24078.
- Neutrophil elastase enhances IL-1 beta secretion from coronary endothelium via an endolysosomal mediated mechanism, without caspase-1 activation. ANGIOGENESIS, 17(4), 941-941.
- . Heart, 100 Suppl 3, A116-A117.
- . Ann Neurol, 75(5), 670-683.
- . Heart, 100 Suppl 1, A2.
- . J Exp Med, 209(11), 1919-1935.
- . JOURNAL OF THE AMERICAN HEART ASSOCIATION, 1(3).
- . Arterioscler Thromb Vasc Biol, 31(9), 1988-1990.
- . Atherosclerosis, 215(2), 348-354.
- . Am J Pathol, 179(4), 1693-1705.
- . Atherosclerosis, 215(2), 348-354.
- . Cardiovasc Res, 85(1), 38-44.
- . Atherosclerosis Supplements, 10(2), e463-e463.
- . Circulation, 119(1), 116-122.
- . PLoS One, 4(4), e5073.
- . Am J Pathol, 168(4), 1396-1403.
- . Cardiovascular Pathology, 13(3), 116-117.
- . Cardiovascular Pathology, 13(3), 117-117.
- . Circulation, 103(8), 1135-1141.
- . Cardiovasc Drug Rev, 19(4), 329-344.
- . Circulation, 99(20), 2617-2620.
- . Circulation, 98(16), 1657-1665.
- 1MHz ultrasound enhances transfection of porcine aortic endothelial cells in vitro and oligonucleotide uptake in an organ culture model.. AMERICAN JOURNAL OF CARDIOLOGY, 82(7A), 29S-29S.
Conference proceedings papers
- . Heart, Vol. 104(Suppl 6) (pp A102-A103), 4 June 2018 - 6 June 2018.
- . Heart, Vol. 102(Suppl 6) (pp A114.2-A114), 6 June 2016 - 8 August 2016.
- . Heart, Vol. 101(Suppl 4) (pp A107.2-A107)
- . HEART, Vol. 99 (pp A99-A99)
- . The Lancet, Vol. 381, Supplement 1 (pp S47 --S47 -)
- . HEART, Vol. 98 (pp A1-A1)
- . D97. PULMONARY HYPERTENSION: NEW INSIGHTS INTO CAUSES AND TREATMENTS?
- . THORAX, Vol. 66 (pp A3-A3)
- . HEART, Vol. 97(20) (pp 10-10)
- . B61. PULMONARY HYPERTENSION: EXPERIMENTAL MODELS I
- . THORAX, Vol. 65 (pp A68-A68)
- IL-1 MODULATES BLOOD PRESSURE IN MICE AND MAN. ATHEROSCLEROSIS SUPP, Vol. 10(2)
- IL-1 MODULATES BLOOD PRESSURE IN MICE AND MAN. ATHEROSCLEROSIS SUPPLEMENTS, Vol. 10(2). Boston, MA, 14 June 2009 - 18 June 2009.
- A NOVEL MURINE MODEL OF STENTING. HEART, Vol. 95 (pp A37-A38)
- The platelet P2Y12 receptor influences the vessel wall response to arterial injury and thrombosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 51(10) (pp A291-A291)
- Modulation of MSS1, a component of the 26S proteasome, in vascular smooth muscle cells in vitro and following experimental PTCA. EUR HEART J, Vol. 22 (pp 3-3)
- IL-1 beta synthesis and neovascularisation following porcine coronary arterial injury. J VASC RES, Vol. 35(5) (pp 389-389)
- Is local drug delivery truly a low efficiency procedure?. AM J CARDIOL, Vol. 80 (pp TC240-TC240)
- Neutrophil elastase enhances IL-1 beta secretion from coronary endothelium via an endolysosomal mediated mechanism, without caspase-1 activation. ANGIOGENESIS, Vol. 17(4) (pp 941-941). California, USA, 18 October 2014 - 23 October 2014.
Preprints
- Teaching interests
-
I teach on several undergraduate and postgraduate taught modules, including MBB334 Biochemical Basis of Human Disease, CDL301 Cardiovascular Pharmacology: Personalising Medicine, several modules within both the MSc in Molecular Medicine, and within the CDLT01 MRes Cardiovascular Medicine: From Molecules to Man.
I am the module co-ordinator for CDL301/6301, module lead CDL601 and CDL602 (Research Skills), deputy module lead for CDL601 (Literature Review) and CDL401 (Vascular Cell Biology), and occasionally deputise for the overall programme of CDLT01 MRes Cardiovacular Medicine:From Molecules to Man. In addition, I also am responsible for the Blackboard site, for CDL302 (Pharmacology of Respiratory Disease).
I am Deputy Director of Learning & Teaching for the Department. I am Chair of the Department鈥檚 Undergraduate Teaching Committee, and am a member of the MRes Committee. I have a particular interest in supporting students with an SpLD, and actively engage in delivering CPD to staff with respect to the use of new teaching technologies and ensuring their teaching is inclusive to all students.